UPLOAD Filing
Cyclerion Therapeutics, Inc.
Date: May 12, 2025 · CIK: 0001755237 · Accession: 0000000000-25-005035
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-287006
Letter
Re: Cyclerion Therapeutics, Inc. Registration Statement on Form S-3 Filed May 6, 2025 File No. 333-287006 Dear Regina Graul:
May 12, 2025
Regina Graul Chief Executive Officer Cyclerion Therapeutics, Inc. 245 First Street, 18th Floor Cambridge, MA 02142
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Doris Stacey Gama at 202-551-3188 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: William J. Michener, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> May 12, 2025 Regina Graul Chief Executive Officer Cyclerion Therapeutics, Inc. 245 First Street, 18th Floor Cambridge, MA 02142 Re: Cyclerion Therapeutics, Inc. Registration Statement on Form S-3 Filed May 6, 2025 File No. 333-287006 Dear Regina Graul: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Doris Stacey Gama at 202-551-3188 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: William J. Michener, Esq. </TEXT> </DOCUMENT>